Skip to main navigation

Home
About
Pipeline
Science
For Patients
Jobs
Investors
Contact

News Releases

Site - News & Events

News Releases
Presentations and Events

News Releases

Year

Oct 15, 2020

Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual Meeting

Sep 24, 2020

Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

Sep 21, 2020

Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer

Sep 09, 2020

Leap Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference

Aug 24, 2020

Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans

Aug 13, 2020

Leap Therapeutics Reports Second Quarter 2020 Financial Results

Jun 25, 2020

Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Jun 22, 2020

Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants

Jun 18, 2020

Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants

Jun 17, 2020

Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Print Page

Email Alerts

Contact Us

© 2020 Leap Therapeutics, Inc.
All Rights Reserved
Terms of Use
Privacy Policy